But Youle’s dismissal, along with 10 others at the NIH’s National Institute of Neurological Disorders and Stroke, underscores ...

After a months-long pause, advisory councils for the National Institutes of Health are restarting, paving the way for the ...

Modern medicine is a field of research that is constantly evolving, driving groundbreaking discoveries that have saved ...

A harmful form of the tau protein, which builds up in Alzheimer's disease and similar brain disorders, can directly damage blood vessels in the brain ...

“This grant allows us to explore the intersection of environmental, socioeconomic, and health factors influencing stroke outcomes,” said Dr. Sanelli, professor, Institute of Health System Science at ...

Chronic pain, a common and debilitating condition, often leads practitioners to prescribe opioids in escalating doses.

The first ALS patient has been enrolled in an NIH-funded expanded access program trial evaluating MN-166 (ibudilast).

New study links norepinephrine to reduced brain inflammation in Alzheimer’s, offering a potential early treatment target.

Vulnerable populations, particularly those with Alzheimer’s disease and related dementias (ADRD), may experience greater health disparities due to the combined impact of socioeconomic stressors ...